eQ OYJ:N TILINPÄÄTÖSTIEDOTE 2016 – eQ:N TULOS KASVOI 23%, OMISTAJILLE EHDOTETAAN JAETTAVAKSI 0,50 EUROA OSAKKEELTA
/
Date03 Feb 2017
eQ OYJ TILINPÄÄTÖSTIEDOTE 3.2.2017, klo 8:00 Tammi-joulukuu 2016 lyhyesti Konsernin nettoliikevaihto kasvoi 16 prosenttia ja oli tilikaudella 35,4 miljoonaa euroa (30,5 M€... Read More →
Ramaco Resources, Inc. Prices Initial Public Offering
/
Date03 Feb 2017
LEXINGTON, Ky., Feb. 02, 2017 (GLOBE NEWSWIRE) — Ramaco Resources, Inc. (NASDAQ:METC) (“Ramaco”) announced today the pricing of its initial public offering of 6,000,000 shares... Read More →
Ársreikningur fagfjárfestasjóðsins KLS vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins KLS vegna ársins 2016
Annual financial statement of Arion Bank Mortgages Institutional Investor Fund (ABMIIF) for 2016
/
Date02 Feb 2017
Annual financial statement of Arion Bank Mortgages Institutional Investor Fund (ABMIIF) for 2016
Ársreikningur fagfjárfestasjóðsins Arion Bank Mortgages Institutional Investor Fund (ABMIIF) vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins Arion Bank Mortgages Institutional Investor Fund (ABMIIF) vegna ársins 2016
Ársreikningur fagfjárfestasjóðsins OFAN VÍ vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins OFAN VÍ vegna ársins 2016
Stemline Therapeutics Provides Update on Pivotal BPDCN Trial
/
Date02 Feb 2017
NEW YORK, Feb. 02, 2017 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, provides an update on its... Read More →
Ársreikningur fagfjárfestasjóðsins REG 1 vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins REG 1 vegna ársins 2016
Ársreikningur fagfjárfestasjóðsins REG 2 Smáralind vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins REG 2 Smáralind vegna ársins 2016
Ársreikningur fagfjárfestasjóðsins SRE fjármögnun 2 vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins SRE fjármögnun 2 vegna ársins 2016